Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

BGLC Relative to the S&P 500

BGLC Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the BioNexus Gene Lab Corp. (NASD:BGLC) seasonal charts above shows that a Buy Date of October 25 and a Sell Date of February 15 has resulted in a geometric average return of 45.39% above the benchmark rate of the S&P 500 Total Return Index over the past 4 years. This seasonal timeframe has shown positive results compared to the benchmark in 3 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 4 years by an average of 117.44% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Industrials sector, which runs from October 29 to May 10. The seasonal chart for the broad sector is available via the following link: Industrials Sector Seasonal Chart.

A word of caution: Only 4 years of data is available for shares of BGLC, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded by Liew Choong-Chin on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.

To download BGLC seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: BGLC